SCHEMBL9738817

SCHEMBL9738817

CC(C)n1nc(C(Oc2ccccc2)Oc2ccccc2)nc1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.34

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 1/20 0.34
AGTR1 P30556 2/20 0.33
AGTR2 P50052 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9739338 0.89 AGTR1 (0.33) CNR2AGTR1AGTR2
SCHEMBL9739129 0.88 AGTR1 (0.35) CNR2AGTR1AGTR2
SCHEMBL9738526 0.87 AGTR1 (0.36) AGTR1AGTR2
SCHEMBL9739460 0.86 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL9739916 0.85 AGTR1 (0.34) CNR2AGTR1
SCHEMBL9739438 0.84 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL9739938 0.84 AGTR1 (0.35) CNR2AGTR1
SCHEMBL9737759 0.84 TRPV1 (0.33) AGTR1AGTR2
SCHEMBL9739204 0.83 AGTR1 (0.32) CNR2AGTR1AGTR2
SCHEMBL9738288 0.82 SLC33A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO claimed
WO-1992005161-A1 1,3,5-TRISUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-04-02 WO disclosed